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ABSTRACT 
This study aimed to provide a more comprehensive picture of the prevalence of autism spectrum 
disorder (ASD) in a geographic cohort of extremely preterm born adolescents by using 
established diagnostic instruments in addition to screening instruments. 53 participants passed 
a screening procedure with two screening instruments and a diagnostic evaluation with a semi-
structured assessment and a parent interview. 28% of the adolescents had a community based 
clinical diagnosis of ASD. When research diagnoses were also taken into account, this rate 
increased to 40%. Intellectual disability, language impairment and behavioural difficulties are 
characteristic for these children with ASD. This study is to our knowledge the first to use ASD-
specific diagnostic instruments to confirm ASD diagnoses in extremely preterm born children 
in early adolescence. The study expands findings of previous research and raises the need for 
follow-up into late childhood and early adolescence. 
  
3 
 
3 
 
KEYWORDS 
Extremely preterm born children 
Late childhood and early adolescence 
Screening tools and ASD specific diagnostic measurements 
High prevalence of ASD 
  
4 
 
4 
 
INTRODUCTION 
In the past decades, major advances in perinatal care have increased the survival rate of 
extremely preterm born children, born before 27 weeks of gestation (1). Follow-up studies have 
shown that these children are often confronted with developmental problems and psychiatric 
diagnoses in late childhood and early adolescence (2–9). Studies also suggest a link between 
extreme prematurity and autism spectrum disorder (ASD), characterised by persistent deficits 
in social communication and social interaction, and restrictive and repetitive patterns of 
behaviours, interests or activities (10). Prematurity and low birth weight are considered to be 
risk factors for ASD (11–17). Two recent studies even found a gradual increased risk of traits 
of ASD with shorter gestation (18,19). Screening studies in early childhood revealed that 
features of ASD have a disproportionally higher prevalence in the preterm compared to the 
general population (20–23). Studies with the Modified-Checklist for Autism in Toddlers (M-
CHAT) (24,25) found screening percentages between 21 and 41% (20–22). The use of multiple 
screening instruments, resulted in comparable percentages (26,27).  
Screening in late childhood and early adolescence revealed similar results. Hack and 
colleagues (2009) (28) examined a group of 8-year-old children (birth weight < 1000 g) and 
found higher symptom severity scores in these children compared with term peers. In another 
study, scores on the Autism Spectrum Screening Questionnaire (29) were higher for very 
preterm adolescents (gestational age < 32 weeks), compared with their term-born counterparts 
(30). 
Since several studies indicated that the high frequency of neurological, cognitive and 
sensory difficulties may give rise to false-positive screening classifications for ASD 
(21,22,26,31), a diagnostic evaluation to confirm true rates of ASD is indicated. To our 
knowledge, only one study confirmed a positive ASD screen with a further assessment in late 
childhood: of the 15.8% children with a positive screen on the Social Communication 
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Questionnaire (SCQ) (32), 8% was diagnosed with ASD following a psychiatric evaluation at 
11 years (33). However, clinical assessment involving direct observation by a clinician was not 
performed (26). The only studies that did include a direct observation measure were conducted 
with infants (2 years; birth weight < 1500 g) (27) and older adolescents (16 - 21 years; birth 
weight < 2000 g) (34) and resulted in prevalence rates of 13% (27) and 5% (34), respectively.  
To conclude, a detailed observation of the prevalence of ASD using both parent report 
and direct observation is not yet available for the age group between 11 and 16 years. The 
current study therefore aims to provide a more substantiated picture of ASD prevalence in 
extremely preterm born children in their early adolescence by using internationally established 
diagnostic instruments in addition to screening tools. IQ, language, and behavioural 
characteristics of children with and without ASD are compared.  
METHODS 
Participants 
Participants in this study belonged to the Extremely Preterm Infants in BELgium 
(EPIBEL) cohort. In this cohort, perinatal data of all the children born before 27 weeks of 
gestation in a two-year period (1999 and 2000) were collected (35). At 3 years of age, the 
cognitive and motor development of the Flemish (Dutch-speaking) children (n = 91) was 
assessed (36) with the Bayley Scales of Infant Development – II (37). For the current study, 
this group was tested again at the age of 11 - 15 years. 
All 91 children included in the 3-year follow-up study were eligible. However, five (5%) 
of the families moved abroad and seven (8%) were excluded because Dutch was not their 
mother tongue. The remaining 79 families were contacted by the developmental centres who 
were responsible for the follow-up of the children in the first years of life, because according 
to the Belgian privacy law, their home addresses were not available to the authors. Of these 79 
families, 66 (84%) replied. The other families could not be reached due to changed contact 
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information (11%) or no response (5%). Of the 66 responding families, 13 (20%) chose not to 
participate. As such, data of 53 children of the Flemish part of the EPIBEL cohort (67%) were 
collected. 
Participants were 32 (60%) boys and 21 (40%) girls with a mean age of 12.60 years (SD 
= 1.03; range: 11 - 15); mean birth weight was 791.75 g (SD = 179.08; range: 400 - 1210). 
Mean age of mothers at birth was 27.81 years (SD = 4.18, range: 20 - 38). Nine children (17%) 
suffered from cerebellar haemorrhage grade III or IV and three children from cystic 
leukomalacia (6%). At the age of three, nine children (17%) were diagnosed with a central 
motor deficit. Currently, eight children showed major motor impairments (e.g., cerebral palsy) 
and eight suffered from major visual impairment or blindness. Another three children had 
auditory difficulties. Eighteen children were part of a twin and four children formed a 
quadruplet. 
Birth weight (t(89) = -.09, p = .930), gestational age (U = 933.50, p = .901), and age of 
mother at birth (U = 913.50, p = .582) were not significantly different between participants and 
drop-outs (n = 38). The percentage of drop-outs with cerebellar haemorrhage grade III or IV (n 
= 7, 18%) or cystic leukomalacia (n = 3, 9%) did not differ significantly from the percentage in 
the participating group (χ²(1) = 0.03, p = .859, χ²(1) = 0.18, p = .672). Nine drop-outs were 
diagnosed with a central motor deficit at the age of three, which is not significantly different 
from the number in the participating group (χ²(1) = 1.48, p = .223). The difference in 
psychomotor developmental index was marginally significant (drop-outs M = 66.60, SD = 
14.76; participating M = 74.87, SD = 19.09; t(62) = -1.84, p = .070). However, drop-outs had a 
significantly lower mental developmental index (M = 72.29, SD = 17.27); t(69) = -2.60, p = 
.010) at the age of 3 than participating children (M = 83.81, SD = 18.86). 
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Materials 
Two validated questionnaires were used to estimate ASD symptoms. Firstly, the SCQ 
lifetime version (32), a 40-item parent questionnaire, was used. Total scores were compared 
with the established cut-off to screen for ASD (i.e., 15). External validity of the SCQ as a first-
level screen for ASD in at-risk samples was demonstrated (sensitivity .88 - .96, specificity .72 
- .80) (38,39) and sufficient internal validity was also established (40). Also the Social 
Responsiveness Scale (SRS) (41,42), a 65-item questionnaire, was administered. A total T-
score above the established cut-off of 60 indicates mild to severe shortcomings in social 
functioning, characteristic for children with mild to severe autistic symptomatology. The SRS 
is characterised by good internal consistency (Cronbach's alpha > .92) (42), good concurrent 
validity (42,43) and high sensitivity (.90) and specificity (.88) (42). Parents were asked to 
complete both questionnaires. 
The diagnostic evaluation included the Autism Diagnostic Observation Schedule 
(ADOS) (44) and the Autism Diagnostic Interview-Revised (ADI-R) (45). The ADOS is a semi-
structured assessment of communication, social interaction and play. In this study, module 3 
was used and ADOS2-algorithms were applied (46). There is significant evidence for sensitivity 
and specificity for the ADOS in differentiating children with ASD from children with non-
spectrum disorders (46). Inter-rater agreement for diagnostic classification ranged from 81% to 
93% and internal consistency for all domains and modules ranged from .47 to .94 (44). We 
aimed to assess the functioning of all participating children with the ADOS. 
The ADI-R, a semi-structured interview in which parents are questioned about their 
child’s social and communication development, was administered when children had a 
community based clinical diagnosis of ASD or when ADOS-scores were above the cut-off for 
ASD. Test-retest and interrater reliabilities of the ADI-R are excellent (most intraclass 
correlation coefficients > .90). Internal consistencies of domain scores ranged from .54 to .84. 
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Concurrent validity was very good and criterion validity was excellent. Discrimination between 
ASD versus non-ASD subjects is very good (sensitivity 1.00; specificity > .97) (45). 
Higher scores on both diagnostic instruments are indicative for more autistic traits. Both 
ADOS and ADI-R were administered by the first author, who was trained to research reliability. 
Inter-rater reliability was obtained by scoring of a number of administrations by three other 
trained researchers (MD, PW and HR).  
Intelligence was assessed using an abridged version of the Wechsler Intelligence Scale 
for Children-III (WISC-III) (47,48). With four subscales (Similarities, Picture Concepts, Block 
Design, and Vocabulary), an intelligence quotient was obtained (M = 100, SD = 15). In addition, 
language development was examined by means of the Dutch version of the Clinical Evaluation 
of Language Fundamentals (CELF-IV(-NL)) (49,50), a test for evaluation and diagnosis of 
language difficulties. Testing with four subtests provided us with a core score for language 
development (M = 100, SD = 15). 
Information about medical and psychological diagnostic and treatment history and 
scholastic achievement was obtained using a self-designed questionnaire. Parental, teacher and 
self-ratings of behavioural problems were collected, using the Child Behaviour Checklist 
(CBCL), the Teacher Report Form (TRF) and the Youth Self Report (YSR) (51). In addition, 
the Disruptive Behaviour Disorders Rating Scales (52) (VvGK(53)) was used to screen for 
disruptive behaviour disorders. Higher scores on these questionnaires indicate higher symptom 
prevalence. 
Statistical analyses 
Data were analysed using the Statistical Package for the Social Sciences software 
version 19 (SPSS Inc., Chicago, Il, USA). In the first part of the results section, descriptive 
analyses (e.g., cross tabulations) were performed to provide information about the ASD clinical 
diagnosis status, the ASD diagnostic status based on assessment with the diagnostic instruments 
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and the ASD screening status of the preterm born children. Four groups of children were 
formed. Children with a community based clinical diagnosis of ASD form the clinical ASD-
group. Children with a score above the cut-off for ASD on one or both diagnostic instruments 
(ADOS and/or ADI-R), but without a former community based clinical diagnosis form the 
research ASD-group. The children from these two diagnostic groups are together considered as 
the ASD-group. A third group is defined as the ASD concern-group. This group comprises the 
children with a positive screen for ASD, on one or both screening questionnaires, but without 
a clinical or research diagnosis of ASD. Children without a screen for or a diagnosis of ASD 
are considered as children without ASD (no ASD-group). 
Independent samples t-tests, chi-square analyses and (one-way) ANOVA’s were 
performed to compare developmental characteristics of the different groups of children. 
Analyses are labelled ‘four groups’ when children with a community based clinical diagnosis 
and children with a research diagnosis are considered separately and ‘three groups’ when they 
are considered as one group. Bonferonni post-hoc analyses were applied. 
For all analyses, the overall significance level was set at .05. Significance levels below .10 were 
considered marginally significant. 
Ethics 
This study was approved by the local ethical committee. Both children and parents gave 
written informed consents. 
RESULTS 
Suspicion of ASD 
Based on the scores on the screening questionnaires and diagnostic measures, the 
participating children were divided in four groups reflecting a different grade of suspicion of 
ASD diagnosis. The first group (clinical ASD-group) consisted of 15 (28%) children with a 
community based clinical diagnosis of ASD, received prior to our evaluation. The second group 
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(research ASD-group) consisted of another six (11%) children with a clinical score on one or 
both diagnostic measures, who never received a clinical diagnosis. Of the total sample, 21 
children (40%) thus had a clinical or research diagnosis of ASD. The two groups of children 
together are considered as the ASD-group. A third group (ASD concern-group) comprises the 
children with a positive screen on the SCQ and/or the SRS (n = 12, 23%), but without a clinical 
diagnosis or a clinical score on one or both diagnostic measures. The remaining 20 children 
(38%) belonged to the fourth group of children without any suspicion of ASD. 
Information about diagnostic status was retrieved from clinical diagnostic reports. In the 
first group of 15 (28%) children with a community based clinical diagnosis of ASD, received 
prior to our evaluation, diagnosis was confirmed by a clinical score on the ADOS in nine of 
these children. The other six children had severe (cognitive and motor) impairments and 
behavioural difficulties that made an assessment with the ADOS impossible. Assessments with 
modules 1 or 2 of the ADOS were considered, but it was clear that the children who were unable 
to be assessed with the module 3, due to insufficient testability or severe intellectual or motor 
impairments, were also unable to be tested with another module. Complementary to the ADOS, 
clinical diagnosis was confirmed with the ADI-R in 10 of these 15 children. Two additional 
children had a subclinical score on the part of the algorithm that measures communication 
deficits, but scored clinically on the other parts. Two parents were not willing to participate in 
this part of the study and the interview was not proposed to the parents of one boy, given the 
severe impairments of their child. The clinical diagnosis of this boy was the only one which 
was not confirmed by ADOS or ADI-R. The total percentage of confirmed community based 
clinical diagnoses was thus 26%. 
The second group consisted of six (11%) children with a clinical score on one or both 
diagnostic measures, who never received a clinical diagnosis. Two children had a clinical score 
on both the ADOS and the ADI-R, three children only had a clinical score on the ADOS, but 
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not on the ADI-R and one boy had a clinical score on the ADI-R, but was not assessed with the 
ADOS, due to severe impairments. These children are labelled as children with a research 
diagnosis of ASD.  
A third group of children, which consisted of a substantive part of the children without 
a clinical or research diagnosis, also warrant our concerns, when considering their positive 
screen on the SCQ and/or the SRS (n = 12, 23%). Ten SRS screens were found and on the SCQ, 
parents of five children reported a score above the threshold for ASD.  
The remaining 20 children (38%) belonged to the fourth group of children without any 
suspicion of ASD.  
The screening results of the total clinically evaluated group and the different subgroups 
are shown in Table 1. As depicted, the children in the clinical ASD-group all screened positive 
on at least one of both screeners. In the research ASD-group, the results are less clear. Four 
children screened positive on the SRS, but only two children had a positive screen on the SCQ. 
Significant differences were found between the children with a clinical diagnosis and a research 
diagnosis when considering total T-scores on the SRS (t(19) = 2.63, p = .017) but not the SCQ 
(t(18) = 1.83, p = .085). ADOS and ADI-R scores are also presented in Table 1. Children with 
a clinical or research diagnosis of ASD were more likely to be male (χ²(1, n = 53) = 6.12, p = 
.013). Of those children diagnosed with ASD, 17 were boys (81%) and 4 were girls (19%). 
However, no significant gender differences were found for scores on the screening instruments 
(SCQ t(43) = 1.16, p = .251; SRS t(45) = 0.46, p = .650). 
Insert Table 1 about here 
Intelligence, Language Development and Scholastic Achievement 
One sample t-tests revealed that the total group of assessed preterm born children scored 
significantly below population average (M = 100, SD = 15) for intelligence (M = 80.74, SD = 
18.49; t(46) = -7.13, p < .001) and language development (M = 88.92, SD = 19.71, t(48) = -
12 
 
12 
 
3.94, p = .001). Children who were not able to complete the test (n = 3) were assigned the 
minimum score (being 50 for the WISC-III, and 55 for the CELF-IV-NL) on both tests for these 
analyses. When the children who were not able to complete the intelligence and the language 
tests (clinical ASD-group n = 2, research ASD-group n = 1) were excluded, very similar results 
were obtained. 
Two one-way ANOVA’s showed that the groups of children with or without a positive 
screen or a research or clinical diagnosis of ASD differed significantly in their level of 
intelligence (Table 2; F(2,44) = 5.84, p = .006; F(3,43) = 4.45, p = .008). Bonferonni post hoc 
analyses revealed that the clinical ASD-group separately (p = .005) and the total ASD-group (p 
= .005) differed significantly from the no ASD-group. Of the children in the ASD-group, 47% 
had an intellectual disability (WISC-III score < 70).  
A significant difference was also found for language development (Table 2; F(2,45) = 
4.55 , p = .016; F(3,45) = 4.71, p = .006). The no ASD-group scored significantly higher than 
both the ASD concern-group (p = .044) and the total ASD-group (p = .025). The clinical ASD-
group separately also scored significantly lower (p = .009) than the no ASD-group. Over 50% 
of the children in the total ASD-group had language difficulties, as did 64% of the children in 
the ASD concern-group (CELF-IV-NL score < 85). Children with a clinical diagnosis did not 
differ from children with a research diagnosis in intelligence level (p = 1.000) and language 
level (p = .371). 
Insert Table 2 about here 
The percentage of children in special education was higher in the ASD-group and in the 
ASD concern-group than in the no ASD-group [ASD 67%, ASD concern 67%, no ASD 30%; 
χ²(2) = 6.72, p = .035)].  
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Behavioural Characteristics 
Mean T-scores on the different scales of the Achenbach questionnaires (CBCL n = 45, 
TRF n = 31, and YSR n = 40) can be found in Table 3. Analyses revealed a significantly higher 
level of behavioural difficulties in children in the total ASD-group, in comparison with the no 
ASD-group. Mainly children from the clinical ASD-group showed elevated T-scores 
(Bonferroni post-hoc analyses). Compared to the no ASD-group, significantly more children in 
the clinical ASD-group scored above the clinical cut-off of the CBCL internalizing scale (χ2(1) 
= 10.76, p = .005), the CBCL externalizing scale (χ2(1) = 6.61, p = .037), the CBCL total 
problem scale (χ2(1) = 16.13, p < .001), the TRF internalizing scale (χ2(1) = 6.12, p = .047) and 
the YSR total problem scale (χ2(1) = 6.72, p = .035). Significantly more children of the ASD 
concern-group scored above the clinical cut-off of the CBCL total problem scale (χ2(1) = 7.78, 
p = .021) compared to the no ASD-group. 
Insert Table 3 about here 
Similar results can be found for behavioural disorder symptoms (n = 47). Analyses 
revealed a higher level of attention deficits, hyperactivity/impulsivity, oppositional defiant 
disorder problems and conduct disorders symptoms in children with a clinical diagnosis of ASD 
(please see Table 4).  
Insert Table 4 about here 
DISCUSSION 
This follow-up study expands findings of previous research that demonstrated elevated 
scores on ASD screeners in preterm born children. In this Flemish cohort of children born 
before 27 weeks of gestation, the prevalence of community based clinical and/or research 
diagnoses of ASD was found to be 40%. When only taking into account community based 
clinical diagnoses made before our evaluation, which were confirmed with a clinical score on 
the ADOS and/or the ADI-R, and thus applying a stricter rule to estimate the prevalence rate, 
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the percentage of ASD diagnoses was still 26%. If we would assume that none of the drop-outs 
has a clinical diagnosis of ASD, which is very unlikely, the prevalence rate in the total Flemish 
EPIBEL group would still be 16%.  
This study is to our knowledge the first to use ASD-specific diagnostic instruments to 
confirm ASD diagnoses in early adolescence. We made use of two well-validated instruments 
which are considered the gold standard in the diagnostic process for ASD, namely the ADOS 
and the ADI-R. They are considered to be the instruments with the highest specificity and 
sensitivity in the diagnostic assessment for ASD (54). Use of both instruments and the inclusion 
of clinical diagnostic information, resulted in an extensive coverage of the ASD prevalence in 
this at-risk group.  
This high prevalence rate is remarkable and it obviously exceeds prevalence rates in the 
general population (55) and in other studies that did not use ASD specific instruments. The 
prevalence rates are also considerably higher than those reported in the EPICure study, which 
found a prevalence rate of 8%, based on assessment with a general diagnostic parent interview 
(33).  
In addition to the children with a diagnosis of ASD, our study also discovered a 
significant rate of elevated scores on both screening instruments. Parents rated clinically 
significant social-communicative difficulties in an additional 23% of the children. Especially 
the rate of impairments in social responsiveness, based on data collected with the SRS, is 
notable. These screening results confirm findings of previous research, in which diagnosed 
ASD was considered to be the extreme end of a distribution of symptoms that are generally 
increased in extremely preterm born children (33). These numbers also point out again the 
importance of the use of diagnostic instruments in research as well as in the clinical field. 
Extremely preterm born boys were more likely to be diagnosed with ASD than girls. 
However, the sex ratio in the ASD groups in this study was only 2.79:1. Moreover, no gender 
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differences were found for screening results. Children with ASD were also characterised by a 
lower IQ. Not only were their IQ scores significantly below the mean intelligence score of the 
children without any suspicion of ASD, almost half of the children with a diagnosis of ASD 
were intellectually disabled. These results are in line with results of prevalence studies that 
reported average intelligence in 16 - 56% of all ASD cases (55). In addition, impaired language 
development was also characteristic. Language problems were however not only detected in 
children with a diagnosis of ASD but also in other children who screened positive for ASD. 
Moreover, applying basal scores for both intelligence and language measurements (being 50 
for the WISC-III, and 55 for the CELF-IV-NL) to estimate the intelligence level and language 
development of the children who could not be tested with the instruments we used, may have 
inflated the mean intelligence and language level of the participating children in both the 
clinical and the research ASD-groups, suggesting that the current number may still be an 
overestimation of their overall cognitive and language capacities. However, omitting these 
children from the analyses would have overestimated the overall language and cognitive levels 
even more.  
Data also revealed that parents, teachers and the children themselves with a community 
based clinical diagnosis of ASD reported a significantly higher prevalence of internalizing and 
externalizing problems than those of children without any suspicion of ASD. A higher rate of 
disruptive behaviour disorder symptoms was also pinpointed. These results are comparable with 
results of full term born children with ASD, in which the majority of parents report their child 
with ASD as having internalising or externalising problems (56). 
All these findings confirm suggestions from previous studies, in which ASD is thought 
to represent part of a preterm phenotype (23) which resembles more the pattern seen in children 
with syndromic ASD (21) and thought to have a different pathogenic pathway involving global 
impairment in brain development (33).  
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This study contributes also in other ways to the research field in this area. Firstly, 
population studies focusing only on children born before 27 weeks of gestation are scarce. This 
group of children with an extremely low gestational age made its appearance only in some 
studies, with the EPICure study as the main example. However, caution in applying the 
evidence to the development of recently born extremely preterm children is warranted, since 
medical and neonatal intensive care have developed in the past decade. Moreover, this was only 
the second study to investigate the prevalence of ASD in late childhood and early adolescence. 
Most ASD studies in preterm born children were conducted in infancy, a period of childhood 
in which under- or overestimation of the prevalence of ASD cannot be ruled out. To our 
knowledge, this was also the first study to include the SRS to screen for ASD symptomatology 
in extremely preterm born children and this instrument seems to cover a great deal of the 
difficulties experienced by ex-preterm born children. 
Nevertheless some limitations need to be acknowledged. Although we succeeded in 
reaching 58% of the children of a complete birth cohort (67% of the children who qualified for 
participation) in an area (Flanders) with a population of more than 6 million inhabitants, the 
number of participants is still modest. Generalizing the results to the entire EPIBEL-cohort thus 
needs caution. However, when comparing developmental characteristics of participating and 
non-participating children, a significantly lower mental developmental index at the age of 3 was 
found in the non-participating children. Given the strong association that was found between 
intelligence and diagnostic status of ASD, this finding could suggest an underestimation of the 
prevalence of ASD in this extremely preterm born cohort. On the other hand, we should 
acknowledge the possible increased participation of parents of children with a known ASD or 
with concerns considering the atypical social communicative development of their child. 
However, the study was not announced as focusing on ASD, but as a general developmental 
assessment. Secondly, we were not able to assess all children with both the ADOS and the ADI-
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R because not all the families were willing to take part in both parts of the research. Moreover, 
several children had severe impairments which made an assessment with the ADOS impossible. 
In addition, although we compared the results within the extremely preterm born sample with 
norm scores and prevalence rates in the general population, not including a full term control 
sample to compare with the preterm results, limits the robustness of the findings. Lastly, the 
high rate of twins in the assessed sample may have influenced the results. However, the 
prevalence of ASD in singletons was somewhat higher, but comparable. Mean intelligence and 
language scores were similar when twins were excluded. 
SUMMARY 
This study aimed to provide a more comprehensive picture of the prevalence of autism spectrum 
disorder (ASD) in a geographic cohort of extremely preterm born children in late childhood and 
early adolescence by using established ASD-specific diagnostic instruments in addition to 
screening instruments. 53 children passed a screening procedure with two screening instruments 
(SCQ and SRS) and a diagnostic evaluation with a semi-structured assessment (ADOS) and a 
parent interview (ADI-R). 28% of the adolescents had a community based clinical diagnosis of 
ASD. When research diagnoses were also taken into account, this rate increased to 40%. 
Intellectual disability, language impairment, and behavioural difficulties are characteristic for 
these children with ASD. The study confirms and further documents the elevated risk for ASD 
symptomatology and diagnosis in extremely preterm born children. The high prevalence rate in 
late childhood and early adolescence that exceeds previously reported rates, raises the need for 
early screening and diagnostic follow-up during the first years of life to improve opportunities 
for extremely preterm born children to benefit from early intervention. It also raises the need 
for follow-up into late childhood and early adolescence, considering the suspected age-related 
increase in prevalence rates.  
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TABLES 
Table 1. Total scores on the SRS, the SCQ and mean ADOS and ADI-R scores 
Table 1 
Total scores on the SRS, the SCQ and mean ADOS and ADI-R scores 
 SRS SCQ ADOS ADI-R 
 n Total 
T-score 
Range % 
screens 
n Total 
score 
Range %  
screens  
n  Social 
Affect 
Restricted 
repetitive 
behaviours  
Total 
score  
n  Reciprocal 
Social 
Interaction 
Communication Restricted  
repetitive  
behaviours 
Total 47 72.2  37 - 123 62% 45 11.3  0 - 30 33% 43 3.2  1.0  4.1      
ASD-group 21 90.01  47 - 123 90% 20 16.51  0 - 30 50% 14 7.41  1.792 9.21  18 16.4 10.9 5.1 
Clinical ASD 15 96 .51 68 - 123 100% 14 18.91 7 - 30 57% 9 6.41  2.21  8.71  12 18.7 12.5 6.2 
Research ASD 6 73.71  47 - 108 67% 6 10.7 0 - 28 33% 5 9.21  1.0  10.21  6 11.6 7.8 3.0 
ASD concern 12 71.81 58 - 98 83% 11 13.22  1 - 25 45% 11 1.3 0.8  2.1     
No ASD 14 45.9 37 - 55 0% 14 2.6 0 - 14 0% 18 1.0  0.4  1.4     
Three groups F(2,44) = 34.25, p < .001 F(2,42) = 13.43, p < .001 F(2,40) 
= 
32.38,  
p < .001 
6.54, 
p = .003 
53.29,  
p < .001 
    
Four groups F(3,43) = 32.23, p < .001 F(3,41) = 11.57, p < .001 F(3,39) 
=  
25.02,  
p < .001 
6.34,  
p = .001 
36.49, 
p < .001 
    
SRS Social Responsiveness Scale (41) ; SCQ Social communication Questionnaire (32) ; ADOS Autism Diagnostic Observation Schedule (44) ; ADI-R Autism Diagnostic 
Interview-Revised (45) ; ASD autism spectrum disorder; ASD-group children with a clinical or research diagnosis of autism spectrum disorder; ASD concern children with one or 
two positive screens for autism spectrum disorder; no ASD-group children without a clinical or research diagnosis of ASD or positive screen for ASD; 1significantly different (p < 
.001) from no ASD-group, based on post hoc Bonferonni tests; 2significantly different (p < .01) from no ASD-group, based on post hoc Bonferonni tests; 3significantly different (p < 
.05) from no ASD-group, based on post hoc Bonferonni tests 
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Table 2. Intelligence and language in children with a different grade of suspicion of ASD 
Table 2 
Intelligence and language in children with a different grade of suspicion of ASD 
 WISC-III CELF-IV-NL 
 n M Range n M Range 
Total 47 80.7 42 - 113 48 88.9 55 - 124 
ASD-group  19 72.52 42 - 105 19 82.83 55 - 124 
Clinical ASD 13 69.32 42 - 105 13 77.52 55 - 106 
Research ASD 6 79.5 50 - 103 6 94.3 55 -124 
ASD concern  11 78.4 61 - 97 11 81.63 62 - 106 
No ASD-group  17 91.5 65 - 113 19 99.2 71 - 121 
Three groups F(2,44) = 5.84, p = .006 F(2,46) = 4.94, p = .011 
Four groups F(3,43) = 4.45, p = .008 F(3,45) = 4.71, p = .006 
WISC-III Wechsler Intelligence Scale for Children – III (47,48); CELF-IV-NL Clinical 
Evaluation of Language Fundamentals (49,50); ASD autism spectrum disorder; ASD-group 
children with a clinical or research diagnosis of autism spectrum disorder; ASD concern 
children with one or two positive screens for autism spectrum disorder; no ASD-group 
children without a clinical or research diagnosis of or positive screen for autism spectrum 
disorder; 1significantly different (p < .001) from no ASD-group, based on post hoc 
Bonferonni tests; 2significantly different (p < .01) from no ASD-group, based on post hoc 
Bonferonni tests; 3significantly different (p < .05) from no ASD-group, based on post hoc 
Bonferonni tests 
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Table 3. Mean total scale T-scores and percentage of children scoring above the clinical cut-off score (i.e., 70) on the CBCL, TRF and 
YSR 
 
Table 3 
Mean total scale T-scores and percentage of children scoring above the clinical cut-off score (i.e., 70) on the CBCL, TRF and YSR 
 CBCL TRF YSR 
 n  Internalizing Externalizing Total n Internalizing Externalizing Total n  Internalizing Externalizing Total 
Total group 45 57.8 
(36%) 
51.0 
(16%) 
55.7  
(33%) 
31 57.8 
(32%) 
51.0 
(16%) 
55.7 
(19%) 
40 51.5 
(15%) 
43.8 
(5%) 
46.9 
(8%) 
ASD-group  19 61.61 
(53%) 
55.71 
(20%) 
62.21 
(53%) 
13 65.02 
(54%) 
56.53 
(31%) 
63.02 
(38%) 
15 55.53 
(27%) 
49.72 
(13%) 
54.62 
(20%) 
Clinical ASD 13 65.31 
(62%) 
60.21 
(31%) 
66.51 
(69%) 
8 68.02 
(63%) 
59.53 
(38%) 
64.82 
(50%) 
10 56.93 
(30%) 
53.21 
(20%) 
58.52 
(30%) 
Research ASD 6 53.5 
(33%) 
46.0 
(0%) 
53.0 
(17%) 
5 60.2 
(40%) 
51.8 
(20%) 
60.2 
(20%) 
5 52.8 
(20%) 
42.8 
(0%) 
46.8 
(0%) 
ASD concern  12 61.42 
(42%) 
53.52 
(25%) 
59.61 
(42%) 
8 54.9 
(25%) 
47.3 
(0%) 
52.3 
(0%) 
11 52.0 
(18%) 
41.4 
(0%) 
43.1 
(0%) 
No ASD-group  14 46.7 
(7%) 
41.0 
(0%) 
43.3 
(0%) 
10 50.8 
(10%) 
46.8 
(10%) 
49.2 
(10%) 
14 46.8 
(0%) 
39.4 
(0%) 
41.9 
(0%) 
Three groups F(2,42) 
= 
9.58,  
p < .001 
9.48,  
p < .001 
14.79,  
p < .001 
F(2,28) 
= 
7.09,  
p = .003 
4.27,  
p = .024 
8.69,  
p = .001 
F(2,37) 
= 
3.97,  
p = .027 
5.88,  
p = .006 
6.10,  
p = .005 
Four groups F(3,41) 
= 
9.07, 
p < .001 
11.04, 
p < .001 
14.29, 
p < .001 
F(3,27) 
= 
5.69, 
p = .004 
3.78, 
p = .022 
6.08, 
p = .003 
F(3,36) 
= 
2.91, 
p = .048 
6.21, 
p = .002 
5.87, 
p = .002 
CBCL Child Behaviour Checklist (51); TRF Teacher Report Form (51); YSR Youth Self Report (51); ASD-group children with a clinical or research diagnosis of autism spectrum 
disorder; ASD concern children with one or two positive screens for autism spectrum disorder; no ASD-group children without a clinical or research diagnosis of or positive screen for 
autism spectrum disorder; 1significantly different (p < .001) from no ASD-group, based on post hoc Bonferonni tests; 2significantly different (p < .01) from no ASD-group, based on 
post hoc Bonferonni tests; 3significantly different (p < .05) from no ASD-group, based on post hoc Bonferonni tests 
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Table 4. Mean scores on the VvGK 
Table 4 
Mean scores on the VvGK 
  Attention 
deficits 
Hyperactivity/ 
Impulsivity 
Oppositional 
Defiant 
Disorder 
Conduct 
Disorder 
 n =  M (SD) 
Total group 47 12.3 12.0 12.2 11.7 
ASD-group 21 13.51 13.11 13.51 12.43 
Clinical ASD 15 13.62 13.71 13.91 12.73 
Research ASD 6 13.0 11.5 12.7 11.8 
ASD concern  12 12.2 12.33 12.3 11.8 
No ASD-group  14 10.8 10.1 10.1 10.5 
Three groups  F(2,44) 7.28,  
p = .002 
10.58,  
p < .001 
8.69,  
p = .001 
4.07,  
p = .024 
Four groups F(3,43) 4.94,  
p = .005 
10.09,  
p < .001 
6.18, 
p = .001 
2.96, 
 p = .043 
ASD-group children with a clinical or research diagnosis of ASD; ASD concern children with one or 
two positive screens for ASD; no ASD-group children without a clinical or research diagnosis of or 
positive screen for ASD; VvGK Vragenlijst voor Gedragsproblemen bij Kinderen (53); 1significantly 
different (p < .001) from no ASD-group, based on post hoc Bonferonni tests; 2significantly different 
(p < .01) from no ASD-group, based on post hoc Bonferonni tests; 3significantly different (p < .05) 
from no ASD-group, based on post hoc Bonferonni tests 
 
 
